In March, the company had received approval from the drug regulator to import and sell sodium zirconium cyclosilicate powder ...

Lilly started selling Mounjaro in India in late March for diabetes and obesity, and it was so far available only in 2.5 mg and 5 mg vials ...

With obesity and Type 2 diabetes on the rise, India is emerging as a key battleground for global drugmakers developing next-generation therapies targeting metabolic disorders.

ELI LILLY Lilly started selling Mounjaro in India in late March for diabetes and obesity, beating rival Novo to the market. The doses available were 2.5 mg and 5 mg vials.

Donanemab is administered as a monthly intravenous infusion. The original dosing plan called for 700 mg (two 350 mg vials) every 4 weeks for three doses, followed by 1,400 mg every 4 weeks after ...

Eli Lilly and Company (NYSE: LLY) today announced that the highest approved doses of Zepbound (tirzepatide)—12.5 mg and 15 mg—will soon be available in single-dose vials for $499 per month ...

Zepbound is the latest GLP-1 receptor agonist medication to be approved for weight loss. Learn where to get a prescription for Zepbound online.

Hypertriglyceridemia (triglycerides 200–499 mg/dL) is relatively common in the United States, whereas more severe triglyceride elevations (very high triglycerides, ≥500 mg/dL) are far less frequently ...

Biocon presented its proposal seeking approval for Trastuzumab lyophilized powder for injection 150 mg and 440 mg vials (PGS formulation) for the treatment of Adjuvant Breast Cancer, Metastatic Breast ...

Our data shows rising interest in Reclast infusion cost as more patients with osteoporosis weigh the value of once‑yearly zoledronic acid IV therapy against ongoing fracture risk, clinic visit ...

Large scale proteomic profiling of cell lines can reveal molecular signatures attributed to variable genotypes or induced perturbations, enabling proteogenomic associations and elucidation of ...